The Institute for Molecular Medicine Finland (FIMM) is an international research institute focusing on human genomics and personalised medicine at the Helsinki Institute for Life Science of the University of Helsinki. FIMM integrates molecular medicine research, technology centre and biobanking infrastructures under one roof, promoting translational research in grand challenge projects, specifically, the impact of genome information from the Finnish population in personalised health and medicine, individualised cancer medicine, and digital molecular medicine. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark, and the EU-LIFE Community. More information: www.fimm.fi
FIMM offers postdoctoral researchers an internationally recognised and unique biomedical research environment with an exciting combination of basic and translational research. Situated in the Academic Medical Centre of the University of Helsinki, FIMM operates within and surrounded by national Centres of Excellence of the Academy of Finland, a Nordic Centre of Excellence, research programmes of the Faculty of Medicine, as well as numerous ongoing clinical trials. Researchers at FIMM are able to work closely with the hospital as well as other institutes and departments of the University.
The FIMMPOD Postdoctoral and Senior Researcher Programme is a professional development programme for the postdoctoral and senior researchers at FIMM and aims to enhance research experiences and career opportunities. FIMMPOD organises events in career development, mentoring, and networking, as well as facilitates the recruitment of new postdoctoral researchers to FIMM.
Expressions of interest are now invited from potential postdoctoral researchers for applying jointly with a FIMM research team for a
Marie Skłodowska-Curie Actions (MSCA) Individual Fellowship.
Description of the MSCA Fellowship Programme
The purpose of the MSCA Individual Fellowship (IF) is to support the mobility of researchers and help attract promising foreign researchers to work in the European context (EU Member States and Associated Countries) or outside Europe. The grant typically covers two years' salary, a mobility allowance, research costs and overheads for the host institution. Individual researchers prepare and submit proposals for funding together with their planned supervisor/host organisation. Proposals are judged on their research quality, impact and implementation, the researcher's future career prospects, and the support offered by the host organisation. More information about MSCA Individual Fellowships is available here.
Research Areas of Interest
We welcome expressions of interest in any research area(s) in which FIMM is involved. The specific research topic for an MSCA IF application will be designed together with the FIMM research group.
Eligibility and Requirements
Candidates are expected to hold a doctoral degree in biology, biochemistry, bioinformatics, biotechnology, computer science, genetics, mathematics, medicine, or other related fields, obtained before the MSCA IF deadline of 14 September 2017. Candidates are also expected to have good problem solving, troubleshooting, and analytical skills, be fluent in English, have good interpersonal and written and oral communication skills, and be able to work independently as well as within an international team.
Candidates are required to read carefully the MSCA IF Guide for Applicants to ascertain eligibility, especially with regard to the mobility rules for each scheme, and learn about what will be required of them if selected to apply with a FIMM research group host.
Candidates are invited to express their interest in a host group at FIMM no later than 16 May 2017 at 16.00 EEST by completing the online application form. Please contact Milla Kibble (email@example.com) if you have any questions.
Expression of interest is not a promise of funding or position.
Review of expressions of interest will begin after 16 May 2017. Proposals will be evaluated based on research quality, the researcher's future career prospects and the availability of suitable supervision. The strongest proposals will be selected for continuation, with a FIMM research group host, to the MSCA IF application (deadline 14 September 2017). The FIMMPOD Postdoctoral and Senior Researcher Programme and the University of Helsinki Research Funding Services will provide application preparation support for the potential fellow-group leader teams.
FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centres for molecular medicine in Norway, Sweden and Denmark. At the national level, FIMM was founded in 2007 as a joint research institute of the University of Helsinki (primary host), the Hospital District of Helsinki and Uusimaa, the National Institute for Health and Welfare, and VTT Technical Research Centre of Finland. In the beginning of 2017 FIMM joined the University of Helsinki’s new life science research centre, Helsinki Institute of Life Science HiLIFE, as an operational unit.
Helsinki 15 March 2017
This information is also available in pdf.